Lilly $27Bn US Manufacturing Investment Linked To Trump’s Tariff, Tax Agenda

 
• By Sarah Karlin-Smith

Eli Lilly's move is said to be part of broader industry campaign to invest in America and avoid President Trump's tariffs, but the company also said tax reform is necessary to make the investments.

Lilly banners on stage. Banner's say "inventing for patients," "investing in America."
Eli Lilly announced a new $27bn US manufacturing commitment on 26 February alongside top Trump Administration officials at the Andrew W. Mellon Auditorium in Washington DC. (Sarah Karlin-Smith)

More from Manufacturing

More from Legislation